Replies to post #220576 on Biotech Values

[ronpopeil]

2031from what I’ve heard from several people so that’s a very nice revenue source for this small company over the next 10+ years assuming nvo drug is as huge as some believe. And if Emis can sign other deals then the stock could really do well.